Can-Fite BioPharma CANF Estimates

NYSE CANF
$3.38 +0.03 (+0.74%)
As of: Aug 21, 2026 · 1:38 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Annual Revenue Estimates

Metric 202120222023202420252026202720282029
Reported (Actual) 853,000.00810,000.00743,000.00674,000.00405,000.00--
High Estimate 871,273.781.24 M695,514.730.00206,102.780.002.85 M
Low Estimate 721,210.781.14 M644,661.730.00170,580.760.002.66 M
Consensus Estimate 796,242.281.19 M670,088.230.00188,341.770.002.75 M

Annual Earnings Per Share (EPS) Estimates

Metric 202120222023202420252026202720282029
Reported (Actual) -6.00-60.00-60.00-10.59-5.97--
High Estimate -95.76-63.51-25.65-23.71-0.45-0.57-0.24
Low Estimate -112.64-72.09-31.25-27.31-0.53-0.69-0.28
Consensus Estimate -104.20-67.80-28.45-25.51-0.49-0.63-0.26